The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Core Laboratories NV

NYSE: CLB
Last

(U.S.) $117.70

Today's change0.00 0.00%
Updated July 26 4:02 PM EDT. Delayed by at least 15 minutes.
 

Core Laboratories NV

NYSE: CLB
Last

(U.S.) $117.70

Today's change0.00 0.00%
Updated July 26 4:02 PM EDT. Delayed by at least 15 minutes.

Core Laboratories NV closed at (U.S.)$117.70.

Shares have lost 4.33% over the last five days, but have gained 8.24% over the last year to date. This security has outperformed the S&P 500 by 8.54% during the last year.

Key company metrics

  • Open(U.S.) $0.00
  • Previous close(U.S.) $117.70
  • High--
  • Low--
  • Bid / Ask(U.S.) $103.00 / (U.S.) $119.20
  • YTD % change+8.24%
  • Volume0
  • Average volume (10-day)523,136
  • Average volume (1-month)471,585
  • Average volume (3-month)536,224
  • 52-week range(U.S.) $84.50 to (U.S.) $135.49
  • Beta1.43
  • Trailing P/E62.50×
  • P/E 1 year forward72.76×
  • Forward PEG3.64×
  • Indicated annual dividend(U.S.) $2.20
  • Dividend yield1.87%
  • Trailing EPS(U.S.) $1.88
Updated July 26 4:02 PM EDT. Delayed by at least 15 minutes.
S&P TSX0.00%Sector:EnergyIndustry:Oil Related Services & Equipment
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q2/2016Q1/2016Q4/2015Q3/2015
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedJun 30, 201606/30/2016Mar 31, 201603/31/2016Dec 31, 201512/31/2015Sep 30, 201509/30/2015
Revenue148154183197
Total other revenue--------
Total revenue148154183197
Gross profit38415868
Total cost of revenue110113125129
Total operating expense128131159150
Selling / general / administrative11111212
Research & development--------
Depreciation / amortization7777
Interest expense (income), net operating--------
Unusual expense (income)--0160
Other operating expenses, total00-10
Operating income20232447
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets--------
Other--------
Income before tax17202043
Income after tax17151634
Income tax, total14510
Net income17151533
Total adjustments to net income--------
Net income before extra. items17151533
Minority interest0000
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items17151533
Inc. avail. to common incl. extra. items17151533
Diluted net income17151533
Dilution adjustment--------
Diluted weighted average shares44424343
Diluted EPS excluding extraordinary itemsvalue per share0.380.360.360.78
Dividends per sharevalue per share0.550.550.550.55
Diluted normalized EPSvalue per share0.380.350.650.78